 |
|
|
|
|
|
|
|
|
|
|
|
1 to 18 of 18 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Casadesus G, Castellani R, Colom L, Lee H, Moreira P, Nunomura A, Perry G, Petersen R, Wang X, Zhu X. on PAPER: Galasko DR. et al., 2012, Failure of Antioxidants to Treat Alzheimer's Disease: Toward a Homeostatic View of Chronic... 17 May 2012.
|
|
|
 |
|
|
Casadesus G, Castellani R, Lee H, Moreira P, Perry G, Phelix C, Smith M, Zhu X. on PAPER: Zambón D. et al., 2010, Comment by George Perry, Xiongwei Zhu, Rudy J. Castellani, Clyde Phelix, Paula Moreira, Gemma... 1 Apr 2010.
|
|
|
|
|
|
Ashford J, Casadesus G, Greco S, Johnston J, Perry G, Smith M, Tezapsidis N. on PAPER: Lieb W. et al., 2009, Comment by Mark A. Smith, Steven Greco, Jane M. Johnston, J. Wesson Ashford, George Perry,... 13 Jan 2010.
|
|
|
|
|
|
Casadesus G, Lee H, Moreira P, Perry G, Smith M, Zhu X. on PAPER: Keizman D. et al., 2009, Uric Acid: Not Just for Gout Anymore
The major flaw of the antioxidant theory of... 4 Sep 2009.
|
|
|
|
|
|
Casadesus G, Lee H, Moreira P, Perry G, Smith M, Zhu X. on PAPER: Massaad CA. et al., 2009, Strengthening the Links Between Amyloid-β, Mitochondria and Oxidative... 17 Aug 2009.
|
|
|
|
|
|
Bryan K, Casadesus G, Perry G, Smith M. on PAPER: Rocca WA. et al., 2007, Comment by Gemma Casadesus, George Perry, Kathryn Bryan, Mark A. Smith
Estrogen... 9 Sep 2007.
|
|
|
|
|
|
Casadesus G, Garrett M, Perry G, Smith M. on PAPER: Zarros ACh. et al., 2005, The Serotonergic Malady in Alzheimer Disease: Implications for Patients and... 10 Feb 2006.
|
|
|
|
|
|
Casadesus G, Perry G, Smith M. on PAPER: Ioannidis JP. et al., 2005, In Search of “Absolute” Truth: Has the Lab Bench Replaced the “Burning at the... 22 Dec 2005.
|
|
|
|
|
|
Casadesus G, Lee H, Moreira P, Nunomura A, Perry G, Smith M, Zhu X. on NEWS: No Toxicity in Tau’s Tangles?, Neurofibrillary Tangles: Villain or Merely Vilified?
What’s Next?... 22 Jul 2005.
|
|
|
|
|
|
Casadesus G, Perry G, Smith M. on NEWS: Breaking News: Oxidation of Proteins Leads to DNA Cleavage, DNA Fragmentation Mechanism Involving Oxidative Stress:
Relevance to Alzheimer... 7 Jul 2005.
|
|
|
|
|
|
Casadesus G, Perry G, Smith M. on NEWS: Mutant Huntingtin—Trojan Horse or Trebuchet?, Cortico-Cortical Connectivity: A Key Aspect to Neurodegeneration
The work from... 30 Jun 2005.
|
|
|
|
|
|
Casadesus G, Lee H, Perry G, Smith M, Webber K, Zhu X. on PAPER: Andorfer C. et al., 2005, The Wheel of Death: Neuronal Cell Cycle and Alzheimer Disease
There are multiple... 29 Jun 2005.
|
|
|
|
|
|
Casadesus G, Perry G, Smith M. on PAPER: López-Toledano MA. et al., 2004, Neurogenesis in AD: Good, Bad or Ugly?
Propelled by the Democratic National... 25 Aug 2004.
|
|
|
|
|
|
Atwood C, Bowen R, Casadesus G, Perry G, Smith M, Webber K. on SITE POLL: What is the most likely mechanism by which aging contributes to AD pathogenesis?, Sex, Aging and Alzheimer’s Disease
Results from a previous poll on the Alzheimer... 2 May 2004.
|
|
|
|
|
|
Atwood C, Casadesus G, Perry G, Smith M. on NEWS: Coping with Copper—Minute Amount of Metal Plagues Rabbit Brain, Copper: A Role in AD?
Recent exciting findings suggest that copper in drinking water... 17 Sep 2003.
|
|
|
|
|
|
Atwood C, Casadesus G, Perry G, Smith M. on NEWS: Coping with Copper—Minute Amount of Metal Plagues Rabbit Brain, Coping with Copper—Minute Amount of Metal Plaques in Rabbit Brain
The article by... 5 Sep 2003.
|
|
|
|
|
|
Casadesus G, Perry G, Smith M. on NEWS: Blueberries for All?, Dietary Antioxidants and Alzheimer Disease
Gemma Casadesus, Mark A. Smith and George... 4 Aug 2003.
|
|
|
|
|
|
Casadesus G, Joseph J, Perry G, Smith M. on NEWS: News on the Molecular Biology of Aging, Homeostatic Control: Relevance to Alzheimer Disease
7 Jan 2002.
|
|
|
|
|
|
|
1 to 18 of 18 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our most recent Webinar: 
